SOURCE: INC Research

INC Research

August 10, 2011 11:47 ET

INC Research's Dr. Javier Revuelta Perez Selected for PharmaVOICE 100

Executive Director of Clinical Development in Internal Medicine and Women's Health Recognized for Efforts in Driving Change With Clinical Trials Outsourcing

RALEIGH, NC--(Marketwire - Aug 10, 2011) - INC Research, LLC, a therapeutically focused contract research organization (CRO) with a trusted process for delivering reliable results, today announced that Javier Revuelta Pérez, PhD, MBA, executive director, clinical development, Internal Medicine and Women's Health, has been named to the annual PharmaVOICE 100 list as one of the top driving forces in the life sciences industry.

"Dr. Javier Revuelta Pérez is a true change agent. He builds consensus around process to affect positive results and does so with a commitment to ethics and excellence," said Taren Grom, editor and cofounder, PharmaVOICE. "For these, and his other inspirational leadership qualities, PharmaVOICE is honored to count him among this year's list of honorees."

Dr. Revuelta Pérez joined INC Research in July 2009 as senior director and head of clinical operations for Europe, Middle East and Africa. He has more than 14 years of clinical research experience in various positions, including clinical monitoring and project management as well as senior roles in a variety of therapeutic indications. Dr. Revuelta Pérez has international business experience in different roles and sectors, including working experience at the European Commission (Brussels). He currently serves as the president of Asociación Española de Compañías de Investigación Clínica (AECIC), the Spanish CRO association.

"We are very proud that Javier has been recognized for his efforts and dedication in raising the bar for clinical research," said Kelvin Logan, PhD, president, EMEA and Asia at INC Research. "His scientific and operational expertise, cultural background and approach to team-building have successfully facilitated positive change within our company, as well as industry organizations where he holds leadership roles."

Dr. Revuelta Pérez has published several articles about research ethics, including harmonization and implementation of rules and practices across the different European Ethics Committees. He received notoriety on his PhD thesis at Valencia University where he examined the compliance in Europe with the good clinical practice (GCP) norms from the International Conference on Harmonisation (ICH).

Featured in the July/August 2011 issue of PharmaVOICE, Dr. Revuelta Pérez was selected from a group of nominations submitted by readers. Established seven years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life-sciences industry. The distinguished honorees are nominated by thousands of PharmaVOICE readers. The PharmaVOICE 100 are selected based on well-crafted and comprehensive essays describing how individuals inspired or motivated them or affected positive changes as well as other factors, such as community and philanthropic activities.

About PharmaVOICE
PharmaVOICE is expressly written and designed to deliver the views, opinions, and insights of executives who are shaping the direction of the dynamic life-sciences industry. PharmaVOICE has a BPA audited distribution of over 25,000 industry executives and reaches more than 65,000 through its online version, which contains original exclusive bonus content.

PharmaVOICE's unique horizontal editorial approach cuts across industry silos, providing a holistic overview of the life-sciences industry, addressing a range of topics from molecule through market. By engaging compelling personalities from diverse industry sectors, PharmaVOICE provides multiple perspectives on business challenges, trends, and topics. Editorial content sparks dialog, initiates debate, and opens the lines of communication to facilitate and improve business-to-business relationships.

PharmaVOICE's multiple-perspective and in-depth original forums, feature articles, topics, and departments are audience-driven. PharmaVOICE provides executives with useful peer-to-peer insights on a broad range of business practices and topics to wide range of life-science sectors.

About INC Research
INC Research is a therapeutically focused contract research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areas and innovative pediatric and women's health trials. The company's Trusted Process® methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit or follow us @inc_research.

Contact Information